Krystal Biotech (KRYS) Earnings Date & Reports

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

KRYS is expected to report earnings to fall 2.19% to $1.79 per share on August 10

Krystal Biotech KRYS Stock Earnings Reports

Q2'26

Est.

$1.79

Q1'26

Beat

by $0.35

Q4'25

Beat

by $0.12

Q3'25

Beat

by $1.57

Q2'25

Beat

by $0.07

The last earnings report on May 04 showed earnings per share of $1.83, beating the estimate of $1.48. With 90.21K shares outstanding, the current market capitalization sits at 10.13B.

View a ticker or compare two or three

Compare

KRYS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for KRYS